Literature DB >> 22130180

Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension.

Xichun Yu1, Stavros Stavrakis, Michael A Hill, Shijun Huang, Sean Reim, Hongliang Li, Muneer Khan, Sean Hamlett, Madeleine W Cunningham, David C Kem.   

Abstract

BACKGROUND: Orthostatic hypotension (OH) is characterized by an abnormal autonomic response to upright posture. Activating autoantibodies to β1/2-adrenergic (AAβ1/2AR) and M2/3 muscarinic receptors (AAM2/3R) produce vasodilative changes in the vasculature that may contribute to OH.
METHODS: Immunoglobulin (Ig)G from 6 patients with idiopathic OH harboring autoantibodies and from 10 healthy control subjects were examined for: 1) β1AR and M2R activity with a perfused Purkinje fiber assay and PKA assay in H9c2 cells and 2) vasodilator β2AR and M3R activity using a pressurized cremaster resistance arteriole assay. Changes in IgG activity with and without propranolol, atropine, and L-NAME were used to estimate AAβAR, AAM2R, and AAM3R activation of their respective functions.
RESULTS: All six patients had elevated enzyme-linked immunosorbent assay titers to at least one of the receptors compared with controls. βAR-mediated contractility activity and M2R activity were increased in five of the six patients. IgG from all six patients produced a direct vasodilator effect on cremaster arterioles. βAR and nitric oxide synthase blockade led to near normalization of IgG-induced vasodilation.
CONCLUSION: AAβ1/2AR and AAM2/3R are present in some patients with idiopathic OH compatible with an in vivo effect. These autoantibodies and their cardiovascular effects provide new mechanistic insights into the pathophysiology of OH. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130180      PMCID: PMC3259269          DOI: 10.1016/j.jash.2011.10.003

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  16 in total

Review 1.  Prevalence of orthostatic hypotension.

Authors:  Phillip A Low
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

2.  Autoimmune hypertensive syndrome.

Authors:  David C Kem; Xichun Yu; Eugene Patterson; Shijun Huang; Stavros Stavrakis; Bela Szabo; Leann Olansky; Jon McCauley; Madeleine W Cunningham
Journal:  Hypertension       Date:  2007-10-08       Impact factor: 10.190

Review 3.  Beta-adrenergic receptors and nitric oxide generation in the cardiovascular system.

Authors:  L R Queen; A Ferro
Journal:  Cell Mol Life Sci       Date:  2006-05       Impact factor: 9.261

Review 4.  Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy.

Authors:  Steven Vernino; Steve Hopkins; Zhengbei Wang
Journal:  Auton Neurosci       Date:  2008-10-31       Impact factor: 3.145

5.  Calcium measurement in isolated arterioles during myogenic and agonist stimulation.

Authors:  G A Meininger; D C Zawieja; J C Falcone; M A Hill; J P Davey
Journal:  Am J Physiol       Date:  1991-09

Review 6.  Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope.

Authors:  Marvin S Medow; Julian M Stewart; Sanjukta Sanyal; Arif Mumtaz; Domenic Sica; William H Frishman
Journal:  Cardiol Rev       Date:  2008 Jan-Feb       Impact factor: 2.644

Review 7.  The pathophysiology and diagnosis of orthostatic hypotension.

Authors:  David Robertson
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

Review 8.  Postural tachycardia syndrome (POTS).

Authors:  Phillip A Low; Paola Sandroni; Michael Joyner; Win-Kuang Shen
Journal:  J Cardiovasc Electrophysiol       Date:  2009-01-16

Review 9.  Neurogenic orthostatic hypotension: a pathophysiological approach.

Authors:  David S Goldstein; Yehonatan Sharabi
Journal:  Circulation       Date:  2009-01-06       Impact factor: 29.690

Review 10.  Cyclic AMP and mechanisms of vasodilation.

Authors:  K J Murray
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

View more
  19 in total

Review 1.  Current concepts in orthostatic hypotension management.

Authors:  Amy C Arnold; Cyndya Shibao
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

2.  Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism.

Authors:  Hongliang Li; David C Kem; Sean Reim; Muneer Khan; Megan Vanderlinde-Wood; Caitlin Zillner; Daniel Collier; Campbell Liles; Michael A Hill; Madeleine W Cunningham; Christopher E Aston; Xichun Yu
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

3.  Serum Resistin Negatively Correlates with Clinical Severity of Postural Tachycardia Syndrome in Children.

Authors:  Wei Bai; Zhenhui Han; Siyao Chen; Hongxia Li; Jingyuan Song; Jianguang Qi; Ying Liao; Chaoshu Tang; Ping Liu; Yuli Wang; Hongfang Jin; Junbao Du
Journal:  Pediatr Cardiol       Date:  2017-08-21       Impact factor: 1.655

4.  Is postural tachycardia syndrome an autoimmune disorder? And other updates on recent autonomic research.

Authors:  Mitchell G Miglis; Srikanth Muppidi
Journal:  Clin Auton Res       Date:  2020-01-14       Impact factor: 4.435

5.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

Review 6.  New Concepts in Complex Regional Pain Syndrome.

Authors:  Maral Tajerian; John David Clark
Journal:  Hand Clin       Date:  2016-02       Impact factor: 1.907

Review 7.  Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment.

Authors:  Mohammed Ruzieh; Blair P Grubb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-04-25

8.  A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome.

Authors:  Adam M Noyes; Jeffrey Kluger
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-05-15       Impact factor: 1.468

9.  Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies.

Authors:  Melanie Dani; Andreas Dirksen; Patricia Taraborrelli; Miriam Torocastro; Dimitrios Panagopoulos; Richard Sutton; Phang Boon Lim
Journal:  Clin Med (Lond)       Date:  2020-11-26       Impact factor: 2.659

10.  The role of G protein coupled receptor kinases in neurocardiovascular pathophysiology.

Authors:  Tijana Bojic; Emina Sudar; Dimitri Mikhailidis; Dragan Alavantic; Esma Isenovic
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.